Prevalence of endocrinopathies in patients with beta-thalassaemia major-A cross-sectional study in Oman

Oman Medical Journal

Volumn 23, Issue 4, 2008, Pages 257-262

  Mula Abed, Waad Allah ^a   Al Hashmi, Huda ^a   Al Muslahi, Muhanna ^a   Al Muslahi, Hilal ^a   Al Lamki, Mohammad ^a  

^a ROYAL HOSPITAL   (Oman)

Author keywords

Beta thalassaemia; Endocrinopathy

Indexed keywords

ALBUMIN; ALFACALCIDOL; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; DEFERIPRONE; DEFEROXAMINE; ESTROGEN; INSULIN; LEVOTHYROXINE; ORAL CONTRACEPTIVE AGENT; PARATHYROID HORMONE; PHOSPHATE; PHOSPHORUS; PROGESTERONE; PROLACTIN; TESTOSTERONE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHELATION THERAPY; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ENDOCRINE DISEASE; ESTRADIOL BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GONAD FUNCTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOPHYSIS FUNCTION; HYPOTHYROIDISM; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; OMAN; PREVALENCE; TESTOSTERONE BLOOD LEVEL; THALASSEMIA MAJOR; THYROID FUNCTION; THYROID FUNCTION TEST;

EID: 79957939480     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Rajab AG, Patton MA, Modell B. Study of hemoglobinopathies in Oman through a national register. Saudi Med J 2000 Dec;21(12):1168-1172.
2. Al-Riyami A, Ebrahim GJ. Genetic Blood Disorders Survey in the Sultanate of Oman. J Trop Pediatr 2003 Jul;49(Suppl 1):i1-i20.
3. Al-Suliman A. Prevalence of beta-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia. Ann Saudi Med 2006 Jan-Feb;26(1):14-16.
4. Mohammed AM, Al-Hilli F, Nadkarni KV, Bhagwat GP, Bapat JP. Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain. Ann Saudi Med 1992 Nov;12(6):536-539.
5. Miller CJ, Dunn EV, Berg B, Abdouni SF. A hematological survey of preschool children of the United Arab Emirates. Saudi Med J 2003 Jun;24(6):609-613.
6. Karimi M, Jamalian N, Yarmohammadi H, Askarnejad A, Afrasiabi A, Hashemi A. Premarital screening for beta-thalassaemia in Southern Iran: options for improving the programme. J Med Screen 2007;14(2):62-66.
7. Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar changes. Trans Am Pediatr Soc 1925;37:29-30.
8. Thein SL, Clegg JB. Beta-thalassaemia. Baillieres Clin Haematol 1998 Mar;11(1):91-126.
9. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, et al. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994 Sep;331(9):574-578.
10. Britton RS, Ramm GA, Olynyk J, Singh R, O’Neill R, Bacon BR. Pathophysiology of iron toxicity. Adv Exp Med Biol 1994;356:239-253.
11. Burtis CA, Ashwood ER, Bruns DE, eds. Tietz textbook of clinical chemistry and molecular diagnostics. 14th ed. Elsevier Saunders: St. Louis, Missouri, USA; 2006.
12. Hill AB, Hill ID. Bradford Hill’s Principles of Medical Statistics. 12th Ed. Hodder Arnold: London; 1991.
13. Walter PB, Macklin EA, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, et al; Thalassemia Clinical Research Network. Inflammation and oxidant-stress in beta-thalassemia patients treated with iron chelators deferasirox (ICL670) or deferoxamine: an ancillary study of the Novartis CICL670A0107 trial. Haematologica 2008 Jun;93(6):817-825.
14. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003 Aug;3(1):4.
15. Italian Working Group on Endocrine Complications in Non-endocrine Diseases. Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol (Oxf) 1995 Jun;42(6):581-586.
16. Al-Elq AH, Al-Saeed HH. Endocrinopathies in patients with thalassemias. Saudi Med J 2004 Oct;25(10):1347-1351.
17. De Sanctis V, Vullo C, Katz M, Wonke B, Tanas R, Bagni B. Gonadal function in patients with beta thalassaemia major. J Clin Pathol 1988 Feb;41(2):133-137.
18. Moayeri H, Oloomi Z. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major. Arch Iran Med 2006 Oct;9(4):329-334.
19. Kwan EY, Lee AC, Li AM, Tam SC, Chan CF, Lau YL, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. J Paediatr Child Health 1995 Apr;31(2):83-87.
20. Moura MD, Navarro PA, Silva de Sá MF, Ferriani RA, Unzer SM, Reis RM. Hypogonadotropic hypogonadism: retrospective analysis of 19 cases. Int J Gynaecol Obstet 2000 Nov;71(2):141-145.
21. De Sanctis V. Growth and puberty and its management in thalassaemia. Horm Res 2002;58(Suppl 1):72-79.
22. Zervas A, Katopodi A, Protonotariou A, Livadas S, Karagiorga M, Politis C, et al. Assessment of thyroid function in two hundred patients with beta-thalassemia major. Thyroid 2002 Feb;12(2):151-154.
23. Najafipour F, Aliasgarzadeh A, Aghamohamadzadeh N, Bahrami A, Mobasri M, Niafar M, et al. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi Med 2008 Sep-Oct;28(5):361-366.
24. Filosa A, Di Maio S, Aloj G, Acampora C. Longitudinal study on thyroid function in patients with thalassemia major. J Pediatr Endocrinol Metab 2006 Dec;19(12):1397-1404.
25. Angelopoulos NG, Goula A, Rombopoulos G, Kaltzidou V, Katounda E, Kaltsas D, et al. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 2006;24(2):138-145.
26. Aleem A, Al-Momen AK, Al-Harakati MS, Hassan A, Al-Fawaz I. Hypocalcemia due to hypoparathyroidism in beta-thalassemia major patients. Ann Saudi Med 2000 Sep-Nov;20(5-6):364-366.
27. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, et al. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998 Dec;103(4):911-915.
28. Tuomainen TP, Nyyssönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, et al. Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men. Diabetes Care 1997 Mar;20(3):426-428.
29. Merkel PA, Simonson DC, Amiel SA, Plewe G, Sherwin RS, Pearson HA, et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988 Mar;318(13):809-814.
30. Chern JP, Lin KH, Lu MY, Lin DT, Lin KS, Chen JD, et al. Abnormal glucose tolerance in transfusion-dependent beta-thalassemic patients. Diabetes Care 2001 May;24(5):850-854.
31. Suvarna J, Ingle H, Deshmukh CT. Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Indian Pediatr 2006 May;43(5):393-400.
32. Sklar CA, Lew LQ, Yoon DJ, David R. Adrenal function in thalassemia major following long-term treatment with multiple transfusions and chelation therapy. Evidence for dissociation of cortisol and adrenal androgen secretion. Am J Dis Child 1987 Mar;141(3):327-330.
33. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002 May;99(10):3505-3516.